Eggerthella lenta MSMC 77-67 is an anaerobe, Gram-negative, rod-shaped human pathogen that was isolated from abdominal wound.
Gram-negative rod-shaped anaerobe human pathogen genome sequence 16S sequence Bacteria| @ref 20215 |
|
Last LPSN update
2026-02-09 11:18:25 |
| Domain Bacteria |
| Phylum Actinomycetota |
| Class Coriobacteriia |
| Order Eggerthellales |
| Family Eggerthellaceae |
| Genus Eggerthella |
| Species Eggerthella lenta |
| Full scientific name Eggerthella lenta (Eggerth 1935) Wade et al. 1999 |
| Synonyms (3) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 6014 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive  | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 6014 | EUBACTERIUM LENTUM MEDIUM (DSMZ Medium 209) | Medium recipe at MediaDive | Name: EUBACTERIUM LENTUM MEDIUM (DSMZ Medium 209) Composition: Ground beef 500.0 g/l Casitone 30.0 g/l Agar 15.0 g/l Arginine 5.0 g/l K2HPO4 5.0 g/l Yeast extract 5.0 g/l L-Cysteine HCl 0.5 g/l Ethanol 0.19 g/l Vitamin K3 0.05 g/l Hemin 0.005 g/l Resazurin 0.001 g/l NaOH Vitamin K1 Distilled water | ||
| 39743 | MEDIUM 20 - for Anaerobic bacteria | Agar (15.000 g);Glucose (5.000 g);Yeast extract (20.000 g);Tryptone (30.000 g);Cysteine hydrochloride (0.500 g);distilled water (1000.000 ml);Hemin solution -M00149 (25.000 ml) | |||
| 120580 | CIP Medium 20 | Medium recipe at CIP |
| @ref | Spore formation | Confidence | |
|---|---|---|---|
| 125439 | 99.5 |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68380 | 29016 ChEBI | arginine | + | hydrolysis | from API rID32A |
| 68380 | 16024 ChEBI | D-mannose | - | fermentation | from API rID32A |
| 120580 | 4853 ChEBI | esculin | - | hydrolysis | |
| 68380 | 29985 ChEBI | L-glutamate | - | degradation | from API rID32A |
| 68380 | 17632 ChEBI | nitrate | - | reduction | from API rID32A |
| 120580 | 17632 ChEBI | nitrate | + | reduction | |
| 120580 | 17632 ChEBI | nitrate | + | respiration | |
| 120580 | 16301 ChEBI | nitrite | - | reduction | |
| 68380 | 16634 ChEBI | raffinose | - | fermentation | from API rID32A |
| 68380 | 27897 ChEBI | tryptophan | - | energy source | from API rID32A |
| 68380 | 16199 ChEBI | urea | - | hydrolysis | from API rID32A |
| @ref | Chebi-ID | Metabolite | Indole test | |
|---|---|---|---|---|
| 68380 | 35581 ChEBI | indole | - | from API rID32A |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68380 | alanine arylamidase | - | 3.4.11.2 | from API rID32A |
| 68382 | alkaline phosphatase | - | 3.1.3.1 | from API zym |
| 68380 | alkaline phosphatase | - | 3.1.3.1 | from API rID32A |
| 68380 | alpha-arabinosidase | - | 3.2.1.55 | from API rID32A |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68380 | alpha-fucosidase | - | 3.2.1.51 | from API rID32A |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68380 | alpha-galactosidase | - | 3.2.1.22 | from API rID32A |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68380 | alpha-glucosidase | - | 3.2.1.20 | from API rID32A |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 120580 | amylase | - | ||
| 68380 | arginine dihydrolase | + | 3.5.3.6 | from API rID32A |
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 120580 | beta-galactosidase | - | 3.2.1.23 | |
| 68380 | beta-galactosidase | - | 3.2.1.23 | from API rID32A |
| 68380 | beta-Galactosidase 6-phosphate | - | from API rID32A | |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68380 | beta-glucosidase | - | 3.2.1.21 | from API rID32A |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 68380 | beta-glucuronidase | - | 3.2.1.31 | from API rID32A |
| 120580 | caseinase | - | 3.4.21.50 | |
| 120580 | catalase | - | 1.11.1.6 | |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 120580 | DNase | - | ||
| 120580 | gelatinase | - | ||
| 68380 | glutamate decarboxylase | - | 4.1.1.15 | from API rID32A |
| 68380 | glutamyl-glutamate arylamidase | - | from API rID32A | |
| 68380 | glycin arylamidase | - | from API rID32A | |
| 68380 | histidine arylamidase | - | from API rID32A | |
| 120580 | lecithinase | - | ||
| 68382 | leucine arylamidase | - | 3.4.11.1 | from API zym |
| 68380 | leucine arylamidase | - | 3.4.11.1 | from API rID32A |
| 68380 | leucyl glycin arylamidase | - | 3.4.11.1 | from API rID32A |
| 120580 | lipase | - | ||
| 68382 | lipase (C 14) | - | from API zym | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68380 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API rID32A |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 120580 | oxidase | - | ||
| 68380 | phenylalanine arylamidase | - | from API rID32A | |
| 68380 | proline-arylamidase | - | 3.4.11.5 | from API rID32A |
| 120580 | protease | - | ||
| 68380 | pyrrolidonyl arylamidase | - | 3.4.19.3 | from API rID32A |
| 68380 | serine arylamidase | - | from API rID32A | |
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 68380 | tryptophan deaminase | - | 4.1.99.1 | from API rID32A |
| 120580 | tween esterase | - | ||
| 68380 | tyrosine arylamidase | - | from API rID32A | |
| 120580 | urease | - | 3.5.1.5 | |
| 68380 | urease | - | 3.5.1.5 | from API rID32A |
| 68382 | valine arylamidase | - | from API zym |
Metadata FA analysis  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| @ref | 52315 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| @ref | URE | ADH (Arg) | alpha GAL | beta GAL | beta-Galactosidase 6-phosphatebeta GP | alpha GLU | beta GLU | alpha ARA | beta GUR | beta-N-Acetyl-beta-glucosaminidasebeta NAG | MNE | RAF | GDC | alpha FUC | Reduction of nitrateNIT | IND | PAL | L-arginine arylamidaseArgA | ProA | LGA | Phenylalanine arylamidasePheA | Leucine arylamidaseLeuA | PyrA | Tyrosine arylamidaseTyrA | Alanine arylamidaseAlaA | Glycin arylamidaseGlyA | Histidine arylamidaseHisA | Glutamyl-glutamate arylamidaseGGA | Serine arylamidaseSerA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6014 | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 6014 | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 52315 | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | - | - | - | - | - | - | - | - | - | - | - |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|
| 66792 | ASM334000v1 assembly for Eggerthella lenta DSM 15644 | contig | GCA_003340005   | 84112.14  | 84112 | 61.52 | |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 20218 | Eggerthella lenta partial 16S rRNA gene, strain ATCC 43055 | FM207094 | 383 |  | 84112 | |
| 124043 | Eggerthella lenta strain DSM 15644 16S ribosomal RNA gene, partial sequence. | MH740921 | 1377 | | 84112 | |
| 124043 | Eggerthella lenta strain CCUG 34779 16S ribosomal RNA gene, partial sequence. | KX683886 | 1391 | | 84112 | |
| 6014 | GC-content (mol%)62 |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| CRISPR-Cas provides limited phage immunity to a prevalent gut bacterium in gnotobiotic mice. | Rasmussen TS, Koefoed AK, Deng L, Muhammed MK, Rousseau GM, Kot W, Sprotte S, Neve H, Franz CMAP, Hansen AK, Vogensen FK, Moineau S, Nielsen DS. | ISME J | 10.1038/s41396-023-01358-4 | 2023 | | |
| Human gut Actinobacteria boost drug absorption by secreting P-glycoprotein ATPase inhibitors. | Kyaw TS, Zhang C, Sandy M, Trepka K, Zhang S, Ramirez Hernandez LA, Ramirez L, Goh JJN, Yu K, Dimassa V, Bess EN, Brockert JG, Dumlao DS, Bisanz JE, Turnbaugh PJ. | iScience | 10.1016/j.isci.2024.110122 | 2024 | | |
| Metabolism | Identification of volatile metabolites produced from levodopa metabolism by different bacteria strains of the gut microbiome. | Pennington T, Eshima J, Smith BS. | BMC Microbiol | 10.1186/s12866-024-03373-7 | 2024 | |
| Gut bacteria convert glucocorticoids into progestins in the presence of hydrogen gas. | McCurry MD, D'Agostino GD, Walsh JT, Bisanz JE, Zalosnik I, Dong X, Morris DJ, Korzenik JR, Edlow AG, Balskus EP, Turnbaugh PJ, Huh JR, Devlin AS. | Cell | 10.1016/j.cell.2024.05.005 | 2024 | | |
| Genetics | Morphological and Genetic Characterization of Eggerthella lenta Bacteriophage PMBT5. | Sprotte S, Rasmussen TS, Cho GS, Brinks E, Lametsch R, Neve H, Vogensen FK, Nielsen DS, Franz CMAP. | Viruses | 10.3390/v14081598 | 2022 | |
| Safety evaluation of Butyricicoccus faecihominis DSM 34943. | Pitt J, Bauter MR, Kumar R, Hasselwander O, Hibberd AA, Kane H, Wang Q, Auzanneau I, Bry S, David E, Seguinot P, Burns F, Smith AB, Carnovale M. | Toxicol Rep | 10.1016/j.toxrep.2025.102145 | 2025 | | |
| Metabolism | Human gut bacterial metabolism drives Th17 activation and colitis. | Alexander M, Ang QY, Nayak RR, Bustion AE, Sandy M, Zhang B, Upadhyay V, Pollard KS, Lynch SV, Turnbaugh PJ. | Cell Host Microbe | 10.1016/j.chom.2021.11.001 | 2022 | |
| Genetics | A Genomic Toolkit for the Mechanistic Dissection of Intractable Human Gut Bacteria. | Bisanz JE, Soto-Perez P, Noecker C, Aksenov AA, Lam KN, Kenney GE, Bess EN, Haiser HJ, Kyaw TS, Yu FB, Rekdal VM, Ha CWY, Devkota S, Balskus EP, Dorrestein PC, Allen-Vercoe E, Turnbaugh PJ. | Cell Host Microbe | 10.1016/j.chom.2020.04.006 | 2020 | |
| Quantification of Slackia and Eggerthella spp. in Human Feces and Adhesion of Representatives Strains to Caco-2 Cells. | Cho GS, Ritzmann F, Eckstein M, Huch M, Briviba K, Behsnilian D, Neve H, Franz CM. | Front Microbiol | 10.3389/fmicb.2016.00658 | 2016 | | |
| Systems biology elucidates the distinctive metabolic niche filled by the human gut microbe Eggerthella lenta. | Noecker C, Sanchez J, Bisanz JE, Escalante V, Alexander M, Trepka K, Heinken A, Liu Y, Dodd D, Thiele I, DeFelice BC, Turnbaugh PJ. | PLoS Biol | 10.1371/journal.pbio.3002125 | 2023 | | |
| CRISPR-Cas System of a Prevalent Human Gut Bacterium Reveals Hyper-targeting against Phages in a Human Virome Catalog. | Soto-Perez P, Bisanz JE, Berry JD, Lam KN, Bondy-Denomy J, Turnbaugh PJ. | Cell Host Microbe | 10.1016/j.chom.2019.08.008 | 2019 | | |
| Metabolism | Metabolism of Daidzein and Genistein by Gut Bacteria of the Class Coriobacteriia. | Soukup ST, Stoll DA, Danylec N, Schoepf A, Kulling SE, Huch M. | Foods | 10.3390/foods10112741 | 2021 | |
| Evaluation of the microbiota-sparing properties of the anti-staphylococcal antibiotic afabicin. | Nowakowska J, Cameron DR, De Martino A, Kuhn J, Le Fresne-Languille S, Leuillet S, Amouzou Y, Wittke F, Carton T, Le Vacon F, Chaves RL, Nicolas-Metral V, Vuagniaux G. | J Antimicrob Chemother | 10.1093/jac/dkad181 | 2023 | | |
| In Vitro Activity of Gepotidacin against Gram-Negative and Gram-Positive Anaerobes. | Hackel MA, Karlowsky JA, Canino MA, Sahm DF, Scangarella-Oman NE. | Antimicrob Agents Chemother | 10.1128/aac.02165-21 | 2022 | | |
| Pathogenicity | Impact of Variations in Test Method Parameters on In Vitro Activity of Surotomycin against Clostridium difficile and Surotomycin Quality Control Limits for Broth Microdilution and Agar Dilution Susceptibility Testing. | Traczewski MM, Deane J, Sahm D, Brown SD, Chesnel L. | J Clin Microbiol | 10.1128/jcm.02881-15 | 2016 | |
| Amidinoquinoxaline N-oxides: synthesis and activity against anaerobic bacteria. | Gruber N, Fernandez-Canigia L, Kilimciler NB, Stipa P, Bisceglia JA, Garcia MB, Gonzalez Maglio DH, Paz ML, Orelli LR. | RSC Adv | 10.1039/d3ra01184d | 2023 | | |
| Between the Devil and the Deep Blue Sea-Resveratrol, Sulfotransferases and Sulfatases-A Long and Turbulent Journey from Intestinal Absorption to Target Cells. | Szymkowiak I, Kucinska M, Murias M. | Molecules | 10.3390/molecules28083297 | 2023 | | |
| Pathogenicity | Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates. | Snydman DR, McDermott LA, Jacobus NV, Kerstein K, Grossman TH, Sutcliffe JA. | Antimicrob Agents Chemother | 10.1128/aac.02206-17 | 2018 | |
| Antimicrobial activity of bovine lactoferrin against Gardnerella species clinical isolates. | Pino A, Mazza T, Matthews MH, Castellana S, Caggia C, Randazzo CL, Gelbfish GA. | Front Microbiol | 10.3389/fmicb.2022.1000822 | 2022 | | |
| Enzymology | Clinical and microbiological characteristics of Eggerthella lenta bacteremia. | Gardiner BJ, Tai AY, Kotsanas D, Francis MJ, Roberts SA, Ballard SA, Junckerstorff RK, Korman TM. | J Clin Microbiol | 10.1128/jcm.02926-14 | 2015 | |
| Pathogenicity | Comparative in vitro activities of GSK2251052, a novel boron-containing leucyl-tRNA synthetase inhibitor, against 916 anaerobic organisms. | Goldstein EJ, Citron DM, Tyrrell KL, Merriam CV. | Antimicrob Agents Chemother | 10.1128/aac.02580-12 | 2013 | |
| Polyphenols as Drivers of a Homeostatic Gut Microecology and Immuno-Metabolic Traits of Akkermansia muciniphila: From Mouse to Man. | Rodriguez-Daza MC, de Vos WM. | Int J Mol Sci | 10.3390/ijms24010045 | 2022 | | |
| Recent development and fighting strategies for lincosamide antibiotic resistance. | Yang Y, Xie S, He F, Xu Y, Wang Z, Ihsan A, Wang X. | Clin Microbiol Rev | 10.1128/cmr.00161-23 | 2024 | | |
| Pathogenicity | In vitro activity of tomopenem (CS-023/RO4908463) against anaerobic bacteria. | Tanaka K, Mikamo H, Nakao K, Ichiishi T, Goto T, Yamagishi Y, Watanabe K. | Antimicrob Agents Chemother | 10.1128/aac.00595-08 | 2009 | |
| Pathogenicity | In vitro antimicrobial activity of razupenem (SMP-601, PTZ601) against anaerobic bacteria. | Tran CM, Tanaka K, Yamagishi Y, Goto T, Mikamo H, Watanabe K. | Antimicrob Agents Chemother | 10.1128/aac.01038-10 | 2011 | |
| Pathogenicity | In vitro activities of telavancin and six comparator agents against anaerobic bacterial isolates. | Finegold SM, Bolanos M, Sumannen PH, Molitoris DR. | Antimicrob Agents Chemother | 10.1128/aac.00908-08 | 2009 | |
| Pathogenicity | Changes in the antibiotic susceptibility of anaerobic bacteria from 2007-2009 to 2010-2012 based on the CLSI methodology. | Hastey CJ, Boyd H, Schuetz AN, Anderson K, Citron DM, Dzink-Fox J, Hackel M, Hecht DW, Jacobus NV, Jenkins SG, Karlsson M, Knapp CC, Koeth LM, Wexler H, Roe-Carpenter DE, From the Ad Hoc Working Group on Antimicrobial Susceptibility Testing of Anaerobic Bacteria of CLSI. | Anaerobe | 10.1016/j.anaerobe.2016.07.003 | 2016 | |
| Resveratrol affects in vitro rumen fermentation, methane production and prokaryotic community composition in a time- and diet-specific manner. | Ma T, Wu W, Tu Y, Zhang N, Diao Q. | Microb Biotechnol | 10.1111/1751-7915.13566 | 2020 | | |
| Pathogenicity | In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria. | Liebetrau A, Rodloff AC, Behra-Miellet J, Dubreuil L. | Antimicrob Agents Chemother | 10.1128/aac.47.11.3667-3671.2003 | 2003 | |
| Pathogenicity | Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. | Wybo I, Van den Bossche D, Soetens O, Vekens E, Vandoorslaer K, Claeys G, Glupczynski Y, Ieven M, Melin P, Nonhoff C, Rodriguez-Villalobos H, Verhaegen J, Pierard D. | J Antimicrob Chemother | 10.1093/jac/dkt344 | 2014 | |
| Pathogenicity | Antianaerobic activity of sulopenem compared to six other agents. | Ednie LM, Appelbaum PC. | Antimicrob Agents Chemother | 10.1128/aac.01557-08 | 2009 | |
| Pathogenicity | In vitro activities of DX-619 and four comparator agents against 376 anaerobic bacterial isolates. | Molitoris D, Vaisanen ML, Bolanos M, Finegold SM. | Antimicrob Agents Chemother | 10.1128/aac.50.5.1887-1889.2006 | 2006 | |
| Pathogenicity | Antimicrobial susceptibilities and clinical sources of Dialister species. | Morio F, Jean-Pierre H, Dubreuil L, Jumas-Bilak E, Calvet L, Mercier G, Devine R, Marchandin H. | Antimicrob Agents Chemother | 10.1128/aac.00538-07 | 2007 | |
| Pathogenicity | In vitro antianaerobic activity of DX-619, a new des-fluoro(6) quinolone. | Tanaka K, Mikamo H, Nakao K, Watanabe K. | Antimicrob Agents Chemother | 10.1128/aac.00639-06 | 2006 | |
| Pathogenicity | Epidemiology and antimicrobial susceptibilities of wound isolates of obligate anaerobes from combat casualties. | White BK, Mende K, Weintrob AC, Beckius ML, Zera WC, Lu D, Bradley W, Tribble DR, Schnaubelt ER, Murray CK, Infectious Disease Clinical Research Program Trauma Infectious Disease Outcome Study Group. | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2015.10.010 | 2016 | |
| Enzymology | A possible role for Clostridium difficile in the etiology of calf enteritis. | Hammitt MC, Bueschel DM, Keel MK, Glock RD, Cuneo P, DeYoung DW, Reggiardo C, Trinh HT, Songer JG. | Vet Microbiol | 10.1016/j.vetmic.2007.09.002 | 2008 | |
| Pathogenicity | Quality control criteria for testing the susceptibility of anaerobic bacteria to meropenem. | Zabransky RJ, Bayola-Mueller L, Jenkins SG, Pitkin DR, Schreckenberger PC, Celig DM, Spiegel CA | J Clin Microbiol | 10.1128/jcm.28.12.2804-2805.1990 | 1990 | |
| Pathogenicity | Eubacterium lentum ATCC 43055, a new reference strain for quality control of anaerobic susceptibility tests. | Barry AL, Zabransky RJ | J Clin Microbiol | 10.1128/jcm.28.10.2375-2376.1990 | 1990 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive3055.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License